NCT05968846
- Conditions
- Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +10 more
- Locations
-
- University of Tennessee Graduate School of Medicine Knoxville, Tennessee, United States
Clinical trial condition
Immunoglobulin Light-chain Amyloidosis
Explore clinical trials studying Immunoglobulin Light-chain Amyloidosis. Study availability and eligibility vary by location and protocol.
182 public trials
42 recruiting studies
Immunoglobulin Light-chain Amyloidosis trial results
NCT04615572
- Conditions
- Amyloidosis, Blood Protein Disorders, Hematologic Diseases, +16 more
- Locations
-
- University of California, Irvine Health Chao Family Comprehensive Cancer Center Orange, California, United States
- University of California, San Francisco San Francisco, California, United States
- University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States
- Tufts Medical Center Boston, Massachusetts, United States
Completed
Phase 1/2 Study of ZN-d5 for the Treatment of Relapsed or Refractory Light Chain (AL) Amyloidosis
NCT05199337
- Conditions
- AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
- Locations
-
- University of Southern California Los Angeles, California, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
- Tulane University New Orleans, Louisiana, United States
- Washington University St Louis, Missouri, United States
NCT04659798
- Conditions
- Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +17 more
- Locations
-
- H. Puerta del Mar Cadiz, Andalusia, Spain
- Hospital Regional Universitario de Malaga (Carlos de Haya) Málaga, Andalusia, Spain
- H. Universitari Son Espases Palma de Mallorca, Balearic Islands, Spain
- H. Universitario de Araba Vitoria-Gasteiz, Basque Country, Spain
NCT00520767
- Conditions
- Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +11 more
- Locations
-
- Rocky Mountain Cancer Centers/Rocky Mountain Blood & Marrow Transplant Program Denver, Colorado, United States
- Boston University Cancer Research Center Boston, Massachusetts, United States
- Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
- Josephine Ford Cancer Center at Henry Ford Hospital Detroit, Michigan, United States
NCT05028374
- Conditions
- AL Amyloidosis, Amyloidosis, Blood Protein Disorders, +28 more
- Locations
-
- Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
NCT00003353
- Conditions
- Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +18 more
- Locations
-
- CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States
- Sylvester Cancer Center, University of Miami Miami, Florida, United States
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
- CCOP - Evanston Evanston, Illinois, United States
NCT00224393
- Conditions
- Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +10 more
- Locations
-
Not specified
Completed
Ixazomib In Combination With Cyclophosphamide And Dexamethasone for Newly Diagnosed AL Amyloidosis
NCT03236792
- Conditions
- AL Amyloidosis, Alzheimer Disease, Amyloidosis, +19 more
- Locations
-
- Icahn School of Medicine at Mount Sinai New York, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- Weill Cornell Medicine New York, United States
NCT04937777
- Conditions
- AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
- Locations
-
- Allgemeines Krankenhaus Der Stadt Wien (General Hopsital), Universitätsklinik Für Innere Medizin I Klinische Abteilung Für Onkologie (Clinic of Internal Medicine I), Medizinische Universität Wien Vienna, Austria
- University Hospital Ostrava, Clinic of Hematooncology Ostrava, Czechia
- Centre Hospitalier Universitaire de Limoges, Department of Clinical Hematology and Cell Therapy Limoges, France
- Service de Néphrologie, Hémodialyse Et Transplantation Rénale, Hôpital Jean Bernard, Chu Poitiers Poitiers, France